Canada· CA-DIN-02284987
APO-CILAZAPRIL/HCTZ
A cilazapril und diuretika product containing cilazapril (cilazapril monohydrate) + hydrochlorothiazide, registered in Canada by APOTEX INC. The same ATC class is registered in 6 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Cilazapril und diuretika is registered in 6 of 19 countries.
Countries holding a registration under ATC C09BA08 (cilazapril und diuretika), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Cilazapril und diuretika · ATC C09BA08
6 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CILAZAPRIL (CILAZAPRIL MONOHYDRATE) + HYDROCHLOROTHIAZIDE
- Manufacturer
- APOTEX INC
- Country
- Canada (CA)
- ATC code
- C09BA08
- ATC class
- Cilazapril und Diuretika
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
67 interactions on record for cilazapril und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cilazapril und diuretika · interactions on record
67 records
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Cilazapril und diuretika in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainINHIBACE PLUS 5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULACheplapharm Arzneimittel Gmbh
- SwitzerlandInhibace Plus
- CzechiaINHIBACE PLUSCHEPLAPHARM Arzneimittel GmbH, Greifswald
- PolandCazacombiKrka, d.d., Novo mesto
- GermanyDynorm PlusCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Inhibace Plus
- Belgium · Co-Inhibace
- Czechia · Inhibace Plus
- Germany · Dynorm Plus
- Spain · Inhibace Plus
- Greece · Vascace Plus
- Hungary · Inhibace Plus
- Italy · Inibace Plus, Initiss Plus
- Poland · Inhibace Plus
- Portugal · Cilazapril + Hidroclorotiazida Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2ba12aa1-af51-4a12-8343-45b6fdbc0152 GET /v1/drugs/2ba12aa1-af51-4a12-8343-45b6fdbc0152?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02284987",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C09BA08",
"schedule": [
"Prescription"
],
"drug_code": "77051",
"strengths": [
"5 MG",
"12.5 MG"
],
"ahfs_class": null,
"substances": [
"CILAZAPRIL (CILAZAPRIL MONOHYDRATE)",
"HYDROCHLOROTHIAZIDE"
],
"product_categorization": null
}See everything about cilazapril und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.